December 18, 2018
Verona Pharma in second phase testing DPI for COPD patients
Verona Pharma started the second phase of clinically evaluating a dry powder inhaler (DPI) formulation of RPL554 in moderate to…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Approval
December 13, 2018
Lotus Pharmaceuticals welcomes Alvogen’s CEO as its new Chairman
Alvogen’s Chairman & CEO Robert Wessman is the new Chairman of the Board at the publicly listed Lotus Pharmaceuticals in Taiwan, succeeding Andrew Lin. Lotus Pharmaceuticals, which is majority-owned by Alvogen, has been under the leadership and guidance of Lin since 2016.
December 12, 2018
Consequences of microbead: What makes microbeads problematic
In the world of great discoveries that cure or add a positive element to our everyday existence, the invention of microbeads hasn’t proven to be one of them. Not alone in its quick rise to popularity and slow journey to extinction, the microbead is just one of numerous products rushed to market before its long term effects are uncovered.
December 10, 2018
Denali moves from healthy volunteers to dosing Parkinson’s disease patients with its therapeutic candidate DNL201
Denali Therapeutics has started dosing Parkinson’s disease patients with its therapeutic candidate for slowing the progression of disease, in a…
December 10, 2018
Alnylam, Silence settle on royalties on Onpattro in EU, dismiss court proceedings
Silence Therapeutics and Alnylam Pharmaceuticals have settled for royalty on net sales of Onpattro in EU, the companies said in separate press releases Monday, noting they will dismiss court proceedings
December 10, 2018
Basilea pockets €8,84M from milestone sales of antifungal Cresemba in the US
The sale of antifungal Cresemba (isavuconazole) in the United States by Astellas Pharma, kicked off CHF 10 million (€8.84M) payment…
December 10, 2018
ValiRx’s leading anti-cancer therapeutic reduces PSA in phase 2 clinical trial
ValiRx journey of bringing closer to market its leading anti-cancer therapeutic VAL201 for patients with hormone-sensitive and hormone-resistant prostate cancer, took a…
December 6, 2018
Stada increases shareholding in Asian Pymepharco to 72%
Stada said Thursday it increases its indirect shareholding in the Vietnamese pharmaceutical company Pymepharco JSC to 72 percent, with a…
December 4, 2018
Kite’s triel of CAR T cell therapy trial with high number of complete leukemia remission with 1 infusion
Gilead’s company Kite’s trial for KTE-X19, its chimeric antigen receptor T cell therapy for adults with ALL (leukemia), resulted in…
December 4, 2018
Bristol-Myers Squibb to distribute $3.8 billion of pension obligations to its US retirement income plan participants
Bristol-Myers Squibb will transfer $3.8 billion of U.S. pension obligations through a full termination of its U.S. Retirement Income Plan.…